US · Healthcare

International Stem Cell Corp (ISCO)

Biotechnology

International Stem Cell Corp (ISCO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ISCO

P/E ratio

25.00

International Stem Cell Corp (ISCO) — FAQ

What is ISCO's P/E ratio?

The price-to-earnings (P/E) ratio for International Stem Cell Corp (ISCO) is 25.00 (data as of 2026-05-23).

Does International Stem Cell Corp pay a dividend?

Dividend yield is not available in the current snapshot for International Stem Cell Corp (ISCO). Check the MyAverix Finance app for the latest dividend data.

What sector is International Stem Cell Corp in?

International Stem Cell Corp (ISCO) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ISCO listed on?

ISCO is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)